MedTrace Logo

Safety and Efficacy of the Use of Botox on Acne

NCT00765375 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2018-06-29

Study results available
· View outcomes & findings →

Summary

• To determine the safety and efficacy of Botox Treatment in subjects with mild to moderate acne vulgaris defined by the Investigator's Global Assessment (IGA)

Conditions

  • Acne Vulgaris

Interventions

DRUG

Botulinum Neurotoxin Type A

1.5-3 units of Botox/lesion

DRUG

Bacteriostatic saline

.1 cc bacteriostatic saline/lesion

Sponsors & Collaborators

  • DeNova Research

    lead OTHER

Principal Investigators

  • Steven H Dayan, MD F.A.C.S. · DeNova Research

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2008-12-31
Completion
2008-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00765375 on ClinicalTrials.gov